Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) EBT: 2023-2024

Historic EBT for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to -$16.1 million.

  • Artiva Biotherapeutics' EBT fell 41.30% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$61.9 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 128.19% down from last year.
  • As of Q4 2024, Artiva Biotherapeutics' EBT stood at -$16.1 million, which was up 2.42% from -$16.5 million recorded in Q3 2024.
  • In the past 5 years, Artiva Biotherapeutics' EBT ranged from a high of $11.2 million in Q3 2023 and a low of -$16.7 million during Q2 2023.
  • In the last 2 years, Artiva Biotherapeutics' EBT had a median value of -$15.5 million in 2024 and averaged -$11.3 million.
  • Data for Artiva Biotherapeutics' EBT shows a peak YoY increase of 6.90% (in 2024) and a maximum YoY decrease of 246.84% (in 2024) over the last 5 years.
  • Artiva Biotherapeutics' EBT (Quarterly) stood at -$11.4 million in 2023, then plummeted by 41.30% to -$16.1 million in 2024.
  • Its last three reported values are -$16.1 million in Q4 2024, -$16.5 million for Q3 2024, and -$15.5 million during Q2 2024.